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ABSTRACT: The hexapeptide NFGAIL is a highly amyloidogenic
peptide, derived from the human islet amyloid polypeptide (hIAPP).
Recent investigations indicate that presumably soluble hIAPP
oligomers are one of the cytotoxic species in type II diabetes.
Here we use thioflavin T staining, transmission electron microscopy,
as well as ion mobility-mass spectrometry coupled to infrared (IR)
spectroscopy to study the amyloid formation mechanism and the
quaternary and secondary structure of soluble NFGAIL oligomers.
Our data reveal that at neutral pH NFGAIL follows a nucleation
dependent mechanism to form amyloid fibrils. During the lag phase,
highly polydisperse, polymorph, and compact oligomers (oligomer number n = 2−13) as well as extended intermediates (n =
4−11) are present. IR secondary structural analysis reveals that compact conformations adopt turn-like structures, whereas
extended oligomers exhibit a significant amount of β-sheet content. This agrees well with previous molecular dynamic
simulations and provides direct experimental evidence that unordered off-pathway NFGAIL aggregates up to the size of at least
the 13-mer as well as partially folded β-sheet containing oligomers are coexisting.
1. INTRODUCTION
Amyloid formation is a hallmark of various diseases such as
type II diabetes (T2D), Parkinson’s, and Alzheimer’s disease.
In the case of T2D, unstructured human islet amyloid
polypeptide (hIAPP) monomers assemble into highly struc-
tured, β-sheet-rich, insoluble deposits known as amyloid
plaques.1 These plaques are found in more than 95% of T2D
patients, which suggests their direct involvement in β-cell
dysfunction in the pancreas.2−5 Recent studies have shown that
especially early hIAPP oligomers represent the toxic
species.1,5−7 Understanding their detailed structure and the
mechanism leading from monomer to fibrils is crucial to
selectively modulate the assembly pathway.1,7−10
Aggregation prone domains of hIAPP include the fragments
1−8, 8−20, 20−29, and 30−37, all of which form amyloid
fibrils.11−15 While each of these fragments may play a role in
the assembly of the parent hIAPP, the 20−29 region has
garnered the most attention, since chemical modification16,17
or mutations5 in this region disrupt fibril formation. The
22NFGAIL27 fragment within this region is the shortest
known hIAPP sequence capable of forming amyloid fibrils at
pH ∼ 7 and was shown to be cytotoxic towards the pancreatic
cell line RIN5fm.18 In addition, recent evidence suggests the
20−29 domain may play a central role in fibril formation of
full-length hIAPP.19 Thus, many experimental20−22 as well as
theoretical23−28 studies have investigated the assembly
characteristics of NFGAIL. They show that the ionic strength23
influences the NFGAIL assembly and oligomers are formed
due to attractive, hydrophobic interactions between phenyl-
alanine residues.22,25,26,28 Molecular dynamic simulations
further support that hydrophobic interactions lead to the
formation of both disordered and structured aggregates.24,26
However, the dissociation of those disordered oligomers is the
rate-limiting step for the formation of structured aggregates.27
Those can then further evolve into amyloid fibrils composed of
antiparallel β-strands.22,28 The characterization of soluble
oligomers using solution-based Fourier transform-infrared
(FT-IR), circular dichroism (CD), or nuclear magnetic
resonance (NMR) spectroscopy only provides ensemble
averaged information rather than information on individual
oligomeric states. Thus, experimental evidence for the
proposed assembly is still missing.
Gas-phase techniques can isolate and characterize a single
species in the presence of many others without affecting the
underlying equilibrium. In particular, ion mobility-mass
spectrometry (IM-MS), a technique which separates ions
based on their mass, charge, size, and shape, has long been
applied successfully to study the structure and aggregation of
reacting systems29 and more recently has been used to follow
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the assembly of early amyloid intermediates.30−33 In a typical
IM-MS experiment, the analyte is first carefully transferred
from solution into the gas phase using soft ionization
techniques such as electrospray ionization (ESI). These
techniques have been shown to preserve solution backbone
structures of peptides and small proteins34−37 and aggregates
of hexameric peptides38 and Aβ peptides.39 Transferred ions
are then gently pulsed into an IM cell that is filled with an inert
buffer gas, through which they move under the influence of a
weak electric field. Compact ions undergo fewer collisions with
the buffer gas than extended ions and therefore leave the IM
cell earlier. The resulting drift time can further be used to
calculate a rotationally averaged collision cross section (CCS),
which is an instrumentally independent value from which
information about the quaternary structure of amyloid
oligomers can be deduced.38
IR spectroscopy on the other hand is highly dependent on
intramolecular vibrations, which makes it an ideal tool to
obtain detailed structural information.40 For example, the
amide I band, i.e., the CO stretching mode, strongly
depends on the secondary structure adopted by peptides and
proteins.41,42 Antiparallel β-sheet-rich proteins typically feature
an amide I frequency at lower wavenumbers (1610−1640
cm−1) and an additional weak mode at higher wavenumbers
(∼1700 cm−1) compared to helical or turn-like structures
(1648−1670 and ∼1660−1690 cm−1, respectively).37,41,42
Recently, IM-MS was successfully used as a preselection tool
to perform gas-phase IR spectroscopy on individual amyloid
oligomeric states and conformations.43 The data showed that
the tetramers (n = 4) of the two amyloid forming peptides
VEALYL and YVEALL undergo a characteristic transition from
compact and unordered conformations into more extended
and β-sheet-rich versions.43 All of the observed higher-order
oligomers (n ≥ 4) were shown to exhibit an elevated β-sheet
content. Here, we employ IM-MS coupled to gas-phase IR
spectroscopy for the structural characterization of NFGAIL
oligomers.
2. RESULTS AND DISCUSSION
The hexapeptide NFGAIL is the shortest fragment of hIAPP
known to form amyloid fibrils at neutral pH.18 Those fibrils
have been shown to feature antiparallel β-strands and a
morphology similar to full length hIAPP fibrils.21,28,44 In order
to study the tendency of early oligomers to form β-sheets, the
NFGAIL peptide was incubated for two days in ammonium
acetate buffer. This procedure lead to the formation of fibrillar
aggregates with anisometric cross section, a mean apparent
diameter of 20−30 nm, and a few hundreds of nanometers
length (Figure 1a and b). Typical protofilaments have not been
detected. The kinetics of fibril formation was monitored in
real-time using thioflavin T (ThT) assay.45 ThT intercalates
into the cavity of amyloid fibrils, which leads to an increased
fluorescence. Even for high concentrations (4 mM), the
hexapeptide NFGAIL follows a nucleation dependent growth
mechanism (Figure S2), characteristic of classical on-pathway
amyloid formation. The sigmoidal growth behavior can be
divided into lag, growth, and saturation phases. During the lag
phase (20 h), early soluble NFGAIL intermediates are
present.7,18 These transient oligomers are highly polydisperse,
i.e., a multitude of oligomeric states coexist. In addition, they
most likely are polymorph; i.e., they occupy a wide range of
different conformations for one oligomeric state. All species
can interconvert or undergo subunit exchange, but once a so-
called nucleus is formed, the autocatalytical growth phase is
initiated. The nuclei presumably act as a template to assemble
monomers into mature fibrils, which are present at the
saturation phase (see ref 39 for an example).
The mass spectrum (Figure 1c) shows that NFGAIL
immediately forms a wide distribution of oligomers, spanning
from a singly charged monomer n/z = 1/1 (with n = oligomer
number, z = charge) up to a quadruply charged 13-mer n/z =
13/4. All of these oligomers carry much less charge than their
number of peptide strands and are therefore most likely not
disturbed by Coulomb repulsion and derived from solution.
IM-MS further reveals that multiple conformations and higher
oligomeric states of the same m/z value exist (Figures S3, S4,
and S5). CCSs of all these species (Table S4) are displayed as
Figure 1. Structural investigation of NFGAIL oligomers. (a, b)
Negative staining transmission electron microscopy (TEM) images of
a NFGAIL solution (4 mM) in ammonium acetate buffer (10 mM,
pH ∼ 7) show the formation of amyloid fibrils. Scale bars: (a) 500
nm, (b) 100 nm. (c) Mass spectra recorded at two different
instrumental settings on the iMob46 instrument (gray and black line)
indicate for a freshly electrosprayed NFGAIL solution the presence of
multiple oligomers, with n being the oligomer number and z the
charge. (d) Measured collision cross sections (CCSs) as a function of
the oligomer number n. The solid line indicates theoretical CCSs
expected for an idealized spherical growth. The experimental error of
each CCS measurement is less than 1% and smaller than the size of
the symbols.
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a function of the oligomer number in Figure 1d. The solid line
represents an ideal isotropic (i.e., globular) growth behavior,
following the equation σ = σ1·n
2/3, where σ1 is the monomer’s
CCS and n the oligomer number.38 Oligomers exhibiting an
experimental CCS on the isotropic line adopt compact,
spherical conformations consisting of turn-like and/or
unordered structures. Extended oligomers that are deviating
from the isotropic growth model on the other hand are often
partially structured and form helical or β-sheet-rich con-
formations.38,43 Figure 1d shows a variety of compact
(experimental CCSs close to the isotropic line) NFGAIL
oligomers, starting from the singly charged monomer (n/z =
1/1) up to the quadruply charged 13-mer (n/z = 13/4). These
compact oligomers presumably adopt turn-like or unordered
conformations. Interestingly, starting from the tetramer (n =
4), multiple conformations are present. For example, for the
pentamer, these range from compact (n/z = 5/2 with 523 Å2
and n/z = 5/3 with 520 Å2) to highly extended structures (n/z
= 5/3 with 540 and 566 Å2, respectively). Similar extended
conformations are also observed for higher oligomeric states (n
= 6−10). Thus, the NFGAIL tetramer might represent a
structural transition point from unordered/turn-like conforma-
tions into at least partially folded, presumably β-sheet-rich
structures. This observation is consistent with recent results on
the 8−20 fragment where a significant β-sheet content begins
at the tetramer.47 In full-length hIAPP, however, a β-hairpin
conformer is observed for both the monomer and dimer30,48
and is shown to be the conformation that leads to fibrilization.
Further, a multidimensional analytical approach for the full-
length hIAPP shows that in the presence of copper ions
globular and toxic off-pathway hIAPP oligomers are formed,
but in neat hIAPP, a different assembly pathway starting at
tetramer is observed.49 Another IM-MS study also observed
more extended hIAPP versions for n ≥ 4.50
Although IM-MS provides information on the stoichiometry
and overall size of amyloid oligomers, direct details of the fine
structure cannot be deduced. Instead, IM-MS can be used to
preselect individual conformations for a subsequent analysis by
orthogonal techniques such as gas-phase IR spectroscopy. The
combination of IM-MS and IR spectroscopy allows the
individual characterization of m/z- and drift-time-selected
species on the quaternary- as well as the secondary-structure
level. Amide I vibrations (CO stretching modes) are highly
sensitive towards the secondary structure adopted by peptides
and proteins.37,41,42 However, due to the number of vibrational
modes, individual amide I features usually overlap. In
conventional condensed-phase spectroscopy, a deconvolution
procedure is typically used to deduce the relative content of
each motif.51,52 In contrast, such relative populations cannot be
directly obtained from gas-phase infrared multiple photon
dissociation (IRMPD) spectra without making assumptions
about the oscillator strengths. The IRMPD process is based on
the sequential absorption of multiple photons, and the
resulting IR intensity does not scale linearly with the number
of absorbed photons. A deconvolution of IRMPD spectral
features may therefore not be fully quantitative but still
represents a reasonably good representation of the different
structural features contributing to a complex spectral band.
Hence, while we provide “quantitative” percentages of β-sheet
content in a given band, these actually represent the relative
amounts between spectral bands for differing conformations or
oligomeric systems but are less quantitative within a given
band.
Figure 2 shows a set of IRMPD spectra of compact NFGAIL
oligomers (n = 2−11) measured in the wavenumber range
from 1400 to 1800 cm−1. All spectra feature two bands
assigned as amide II (1480−1540 cm−1) and amide I (1600−
1720 cm−1). The amide I region was fitted with multiple
Gaussian curves (for details, see the Supporting Information),
where antiparallel β-sheets and turn-like motifs are labeled in
red and blue, respectively. The center of the amide I band of
the singly charged dimer (n/z = 2/1) appears at 1683 cm−1,
whereas for higher oligomers (n = 3−11) this feature occurs at
lower wavenumbers. The extent of hydrogen bonding within
the dimer is apparently lower than that for larger oligomers and
therefore provides less perturbation for the individual CO
oscillators. The amide I band of higher compact oligomers
appears around 1670 cm−1, which is indicative for turn-like
structures.41−43 This observation agrees with the fact that the
experimental CCSs of these oligomers represent compact,
spherical structures. Interestingly, an additional shoulder
around 1640 cm−1 emerges for the triply charged octamer
(n/z = 8/3), indicating a β-sheet content of approximately 8%.
The experimental CCS of this octamer (n/z = 8/3 with 701
Å2), however, fits well with the theoretical value for a spherical,
compact conformation (694 Å2). A small β-sheet content
observed via IRMPD may not necessarily be correlated with an
extended structural ensemble.
The first NFGAIL oligomers that considerably deviate from
the isotropic line are pentamers. They are highly polymorph
and range from compact (n/z = 5/2 with 523 Å2 and n/z = 5/
3 with 520 Å2) to highly extended (n/z = 5/3 with 540 and
Figure 2. Infrared multiple photon dissociation (IRMPD) spectra of
m/z- and drift-time-selected compact NFGAIL oligomers, exhibiting
experimental CCSs similar to theoretical values predicted by the
isotropic growth model. Fractions of the amide I band that are
representative for β-sheet structures (1600−1640 cm−1) and turn-like
structures (1660−1685 cm−1) are shown in red and blue, respectively.
For details about the fitting procedure, see the Supporting
Information.
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566 Å2) conformations. The individual, conformer-selective IR
spectra show an amide I band at 1674 cm−1, which indicates a
predominantly turn-like structure present for all pentamers
(Figure 3). Interestingly, the more extended pentamer
isoforms exhibit a broader amide I band than that observed
for the corresponding compact species and show additional
features at around 1620−1640 and 1700 cm−1 (red Gaussians).
These features are indicative of antiparallel β-strands. An
amide I deconvolution reveals a β-sheet IR fraction of up to
13%. This observation is in good agreement with previous
results, which suggest a higher β-sheet content for more
extended conformations.38,43 As a result of the non-linear IR
absorption process, however, it is not possible to absolutely
quantify how many single peptide strands within the NFGAIL
pentamer contribute to the β-sheet fraction in the IR spectrum.
For a short peptide such as NFGAIL, the β-sheet IR fraction
originates from the noncovalent assembly of at least two
individual peptide strands. In addition, a recent 2D-IR study
on the full-length hIAPP further suggests that β-sheet-rich
hIAPP oligomers, which are present in the lag phase, are
composed of less than four β-strands.19 Thus, the here
investigated NFGAIL oligomers are likely to be composed of at
least two or three β-strands.
The gas-phase IR spectra of other extended NFGAIL
oligomers (n = 4−9) also show a broad amide I band, with
elevated intensities at 1617−1640 cm−1 (Figure 4). The
Gaussian deconvolution analysis reveals a significant β-sheet
content of up to 24%. There is a significant jump in β-sheet
content from n = 4 (14%) to n = 7 (24%) but no smooth trend
as n increases. Hence, factors beyond oligomer size contribute
to β-sheet formation. A complex equilibrium between
oligomeric states and conformations with different β-sheet
content is established in the early stages of NFGAIL
aggregation (lag phase). Secondary structural transitions
might therefore occur over a multitude of oligomeric states,
as observed for other amyloid forming sequences such as
NNQQNY.38 Similarly to NFGAIL, also the full-length hIAPP
peptide shows a diverse free energy landscape, which is more
complicated than a simple transition from a random-coil
structure into a perfect fiber-like nucleus.19 Thus, the short
NFGAIL peptide might serve as a good model system and
provides critical insights into the full-length hIAPP assembly
mechanism. In addition, the coexistence of both turn-like as
well as partially β-sheet-rich structured aggregates for n = 4−10
is in agreement with a previous theoretical study, which
showed that unstructured NFGAIL oligomers are initially
formed and their subsequent dissociation is the rate-limiting
step for the assembly into higher, β-sheet-rich oligomers.27 The
extended β-sheet-rich NFGAIL oligomers investigated here,
therefore, most likely represent on-pathway oligomers to
amyloid fibrils.
3. CONCLUSIONS
A combination of condensed-phased methods such as ThT
assay and TEM as well as gas-phase methods such as IM-MS
coupled to gas-phase IR spectroscopy was used to study the
kinetics and oligomeric structural evolution occurring in
NFGAIL fibril formation. Under buffered conditions, NFGAIL
follows a nucleation dependent growth mechanism into mature
fibrils. IM-MS analysis reveals that during the lag phase a
variety of oligomeric states n and different conformations
ranging from compact (for n = 2−13) to extended (for n = 4−
10) structures are present. Interestingly, also for the full-length
hIAPP peptide49,50 and other amyloid forming sys-
tems,38,43,48,53 a similar transition from compact to more
Figure 3. Infrared multiple photon dissociation (IRMPD) spectra of
m/z- and drift-time-selected NFGAIL pentamers ranging from
compact (n/z = 5/2 with 523 Å2 and n/z = 5/3 with 520 Å2) to
extended (n/z = 5/3 with 540 Å2 and 566 Å2, respectively) structures.
The amide I band (1600−1700 cm−1) was deconvoluted with
multiple Gaussians representing β-sheets (red) or turn-like (blue)
conformations. One additional Gaussian between 1560 and 1600
cm−1 (gray) was included to compensate for an overlapping amide I
and amide II band. Details of the fitting procedure are given in the
Supporting Information.
Figure 4. Individual infrared multiple photon dissociation (IRMPD)
spectra of extended NFGAIL oligomers. The amide I band (1600−
1700 cm−1) was deconvoluted with multiple Gaussians representing
β-sheets (red) or turn-like (blue) conformations. Details of the fitting
procedure are given in the Supporting Information.
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extended versions has been observed. In all cases, the
conversion typically starts for oligomers as little as two to
nine subunits.49,50 The early transition into more extended,
presumably β-sheet-rich structures might be therefore a general
feature of amyloid forming systems.
The gas-phase IR analysis of compact NFGAIL oligomers (n
= 2−11) shows an amide I band centered at 1670 cm−1,
associated with turn-like structures. Extended NFGAIL
oligomers (n = 4−9), however, exhibit additional IR features
at 1617−1640 cm−1, which are representative of β-sheet-rich
structures. Deconvolution of the amide I band indicates a β-
sheet IR content of up to 24% for extended NFGAIL
oligomers.
A previous theoretical study suggests that the formation of
unstructured aggregates and their subsequent dissociation is
the rate-limiting step to form higher-order, β-sheet-rich
NFGAIL oligomers.27 The data presented here support this
hypothesis by providing the first direct secondary structure
data for individual oligomers. Due to the complex assembly
disassembly assembly cascade, the investigated oligomers range
from largely unordered to significantly folded β-sheet-
containing species, and therefore, for every extended version,
a more compact, unordered counterpart coexists. The
conformational complexity for each NFGAIL oligomer
observed here is in contrast to our previous study43 on
VEALYL and YVEALL where conformational complexity was
limited to only one or two oligomer sizes. This points to
coexistence of on- and off-pathway aggregates in the NFGAIL
system and complex assembly/disassembly dynamics that
ultimately leads to both an on-pathway β-sheet dominated
set of oligomers leading to fibrils and an off-pathway more
isotropic set of oligomers up to at least the size of a 13-mer.
4. MATERIALS AND METHODS
4.1. Samples. The hexapeptide NFGAIL was synthesized
manually according to standard Fmoc chemistry using a preloaded
TGA resin. Peptide purification was performed on a low-pressure
HPLC system. Purity was validated using an analytical HPLC system
and high-resolution mass spectrometry (Figure S1). Further details
can be found in the Supporting Information.
4.2. ThT Assay. An NFGAIL stock solution was prepared by
dissolving the purified NFGAIL in HFIP (1,1,1,3,3,3-hexafluoro-2-
propanol) (∼18 mM) and was further sonicated for 15 min to
dissolve all preformed aggregates. Aliquots of this stock solution were
dried and then redissolved to a final concentration of 4 mM in
ammonium acetate buffer (10 mM, pH ∼ 7), containing 20 μM ThT.
After dissolution, the sample was sonicated for 30 s and then
incubated at 37 °C with 1300 rpm.
Fluorescence spectra were recorded using a 1 cm path length
quartz cuvette (Hellma, Müllheim, Germany) and a luminescence
spectrometer LS50B (PerkinElmer, Boston, MA, USA). Spectra were
recorded at room temperature from 470 to 500 nm after excitation at
420 nm (excitation slit width 5 nm; emission slit width 10 nm; scan
speed = 300 nm/min; accumulations = 3). The fluorescence intensity
at 485 nm was normalized with respect to its maximum value.
4.3. TEM Characterization. Sample preparation was performed
according to ThT assay. The solution was further incubated at 37 °C
and shaken with 1300 rpm for 2 days. During the incubation time, the
formation of insoluble deposition was observed. Samples for staining
electron microscopy were prepared by adsorbing 5 μL aliquots of
peptide solution to glow-discharged carbon-coated collodium films on
400-mesh copper grids. The grids were blotted, stained with 1%
phosphotungstic acid, and air-dried. TEM micrographs were taken by
a FEI Talos L120 TEM operated at 120 kV for morphological
characterization.
4.4. Isomer-Selective IR Spectroscopy. The purified peptide
was dissolved in ammonium acetate (10 mM, pH ∼ 7) to yield a final
peptide concentration of 1 mM. For nESI, ∼8 μL of sample was
loaded into in-house-prepared Pd/Pt-coated borosilicate capillaries,
and voltages of 0.6−1.0 kV were applied.
The ion mobility method for drift-time-based selection is well
established.54 Ions are drift-time-preselected prior to irradiation with
intense IR light using an in-house constructed drift-tube ion mobility-
mass spectrometer similar to one described previously.40,55 After ions
are generated using a nano electrospray ionization (nESI) source, they
are transferred and stored in an entrance funnel. Subsequently, ions
are released by 150 μs long pulses into a drift tube, where they travel
under the influence of a weak electric field (10−20 V/cm) through
helium buffer gas (∼4 mbar). The drift velocity of a particular ion
depends on its mobility, which in turn is based on its overall size,
shape, and charge. After releasing the ion mobility cell, ions are mass-
selected using a quadrupole mass filter and their arrival time
distributions (ATDs) can be recorded by measuring the time
dependent ion current of the m/z-selected species after release of
the ion trap. CCSs are measured on two different IMS instruments:
(1) HiRes55 located in Santa Barbara (resolution, R = 100), which
allows a high IMS separation of individual conformations; (2) iMob46
located in Berlin (R = 40), which is connected to a free electron laser
and therefore allows the recording of conformer- and mass-selected IR
spectra.
Gas-phase IR spectra are recorded on the iMob46 instrument by
selecting a narrow drift-time window (100 μs width) using
electrostatic deflection prior to mass selection. This m/z- and ion-
mobility-selected ion cloud was further irradiated by an intense (10−
40 mJ) 10 μs pulse of IR photons. The photofragmentation is
detected by a time-of-flight (ToF) mass analyzer, and IR spectra are
obtained by plotting the fragmentation yield as a function of the
tunable IR wavenumber. The final IR spectrum represents an average
of at least two individual scans, where each scan was obtained by
scanning in 3 cm−1 wavenumber steps and averaging at least 40
spectra for each step.
The tunable mid-IR light is provided by the Fritz-Haber-Institut
free electron laser and is transported to the instrument via an
evacuated beamline. The last two meters of the beamline are flushed
with dry nitrogen to avoid water absorption.
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